Blogs

Decentralized clinical trials represent a medical research paradigm shift, enhancing patient accessibility and engagement. The future holds increased patient-focused trials driven by regulatory and technological advancements, enabling frequent, less invasive data capture.

TAP® II devices, involves collecting a small blood samples that improves the patient experience, because it’s easier to use than other self-sampling devices.